EU-MDR & MR Clinical Trials The Netherlands

🇳🇱 Submissions in the Netherlands under MDR

This article provides a structured overview for MR-scientists on how to prepare and where to submit the required documents for a medical-device clinical investigation in the Netherlands — including studies using non-CE-marked pulse sequences and/or non-CE-marked RF coils.

Authorities to Submit To

In the Netherlands, “Requests for authorisation of a clinical investigation” must be made to both:

Both a positive ethics decision (MREC/CCMO) and completion of CCMO validation/authorisation steps are required before starting the investigation.

Key Documents Required

The required documents can be divided in 5 groups:

1. Application Forms

  • MDR Clinical Investigation application via the CCMO Research Portal (replaces ToetsingOnline). See CCMO’s Primary submission page and “Standard research file”.
  • When the EUDAMED CI/PS module is required in NL, submit in EUDAMED (CCMO provides bridging instructions until full availability).
  • Cover letter summarising device, investigational components (non-CE sequence/coil), sites, participants, timelines.

2. Clinical Investigation Documentation

3. Safety and Performance Evidence (MR-specific)

  • IEC 60601-2-33 rationale for MR environments (SAR/local-SAR limits; simulations and phantom measurements).
  • RF coil dossier (manufacturer ISO 13485 certificate, coil-file, FDTD/Sim4Life B1+/SAR simulations, phantom thermometry, safety report).
  • Sequence safety (vendor statements that scanner safety controls remain active; watchdogs/limits; access controls to prevent accidental use).
  • Best practices (e.g., ISMRM recommendations for experimental RF hardware) referenced in IB/annexes.

4. Regulatory and Legal Documents

  • Insurance certificate covering participants in the Netherlands.
  • EU Authorised Representative (if sponsor is outside the EU).
  • Data protection: GDPR compliance statement and (where applicable) DPIA.

5. Ethics Committee Package (MREC/CCMO)

  • PIS & ICF (languages per the responsible accredited MREC / CCMO), privacy wording aligned to GDPR; submit via the CCMO Research Portal.
  • Recruitment materials (flyers/posters).
  • Investigator CVs & GCP certificates, site suitability, institutional permissions.

Submission Pathway

  • Competent Authority (CCMO): submit the MDR clinical investigation dossier via the Research Portal. For conformity purposes (MDR Art. 62 / 74.2), CCMO first performs a validation; after a positive validation, the file is forwarded to an accredited MREC or CCMO for review (see Primary submission).
  • Ethics (Accredited MRECs / CCMO): file the ethics dossier through the Research Portal to the competent accredited MREC (or CCMO, where applicable).

Note: In NL, CCMO is the competent authority for registrations/notifications relating to device clinical investigations and manages the national Research Portal. Ethics review is performed by accredited MRECs or CCMO as per study type/risk; timelines are coordinated but independent.

MR-specific notes for studies using non-CE sequences and/or non-CE RF coils

  • Define the investigational device system clearly (CE-marked scanner/software + investigational coil/sequence package) and state risk class in CIP/IB.
  • Evidence package: B1+ maps, SAR/local-SAR analyses, worst-case duty-cycle temperature estimates, phantom thermometry at hotspot locations (e.g., eye and cortical regions).
  • Operational controls: show that scanner SAR/gradient watchdogs remain active with investigational components; document password-protected access and prevention of accidental use.
  • Standards mapping: cross-reference IB/CIP evidence to IEC 60601-2-33 and your applicable standards list; cite ISMRM RF-hardware safety recommendations.

Relevant References

Leave a comment